James Lindsay

Professor James Lindsay is a leading academic and clinical expert in Inflammatory Bowel Disease (IBD), affiliated with the Barts and the London School of Medicine and Dentistry at Queen Mary University of London. He serves as a Consultant Gastroenterologist at Barts Health NHS Trust and leads a multidisciplinary IBD service at The Royal London Hospital.

• Education Officer and Governing Board member, European Crohn’s and Colitis Organisation (ECCO)
• Chief Investigator for clinical trials in IBD, including the NIHR-funded ASTIClite trial
• Collaborates with Dr. Andy Stagg (antigen presentation) and Prof. Andy Silver (microRNA profiles in IBD)

Research Focus: His work spans clinical trials, mucosal immunology, and translational studies addressing mechanisms of IBD, with particular emphasis on stem cell transplantation, dietary interventions, and microbiome dynamics.

• Key articles include studies on low-FODMAP diets, stem cell therapies, and microbiome dysbiosis in IBD

Academic Contributions: He is the IBD module director for the MSc in Gastroenterology and actively supervises translational research programs.

Labs & Collaborations: Based at the Centre for Immunobiology at the Blizard Institute, he works with multidisciplinary teams focused on IBD treatment innovations.